Valuation: Amgen Inc.

Market Cap 20TCr 1,04300Cr 18TCr 16TCr 15TCr 29TCr 19,22400Cr 29TCr 1,94700Cr 76TCr 9,44100Cr 76TCr 74TCr 32,57900Cr P/E 2026 *
24.4x
P/E 2027 * 22.5x
Enterprise Value 24TCr 1,25900Cr 21TCr 20TCr 18TCr 35TCr 23,19400Cr 35TCr 2,35000Cr 91TCr 11,39100Cr 91TCr 89TCr 39,30800Cr EV / Sales 2026 *
6.45x
EV / Sales 2027 * 6.15x
Free-Float
99.78%
Yield 2026 *
2.7%
Yield 2027 * 2.85%
1 day+5.20%
1 week+5.36%
Current month+5.20%
1 month+14.10%
3 months+11.08%
6 months+12.77%
Current year+5.78%
1 week 65.66
Extreme 65.66
69.77
1 month 62.29
Extreme 62.29
69.77
Current year 48.4
Extreme 48.4
78.13
1 year 48.4
Extreme 48.4
78.13
3 years 38
Extreme 38
78.13
5 years 37.52
Extreme 37.52
78.13
10 years 15.78
Extreme 15.7804
78.13
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Director of Finance/CFO 67 01/01/2020
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
+5.20%+5.36% - - 20TCr
+1.86%+0.48%+55.50%+163.08% 1,08200Cr
+3.57%+3.29%+68.60%+61.03% 63TCr
+3.99%+3.05%+37.93%+93.37% 46TCr
+3.86%+1.85%+31.30%+24.86% 34TCr
-0.56%+2.80%+39.13%+28.20% 30TCr
-0.08%+1.52%+29.96%+42.13% 29TCr
-1.54%+3.56%-25.96%-40.53% 23TCr
+4.21%+2.65%+17.47%+71.11% 16TCr
+1.84%+0.12%-4.18%-33.64% 14TCr
Average +2.24%+4.17%+27.75%+45.51% 40.4TCr
Weighted average by Cap. +2.31%+5.28%+40.86%+78.45%

Financials

2026 *2027 *
Net sales 3.78TCr 20TCr 3.3TCr 3.03TCr 2.83TCr 5.36TCr 3,59500Cr 5.44TCr 36TCr 14TCr 1,76500Cr 14TCr 14TCr 6,09200Cr 3.87TCr 20TCr 3.39TCr 3.11TCr 2.9TCr 5.5TCr 3,68600Cr 5.58TCr 37TCr 15TCr 1,81000Cr 15TCr 14TCr 6,24600Cr
Net income 823.15Cr 4.25TCr 719.91Cr 660.73Cr 616.79Cr 1.17TCr 78TCr 1.19TCr 7.94TCr 3.09TCr 38TCr 3.09TCr 3.02TCr 1,32800Cr 886.48Cr 4.58TCr 775.3Cr 711.57Cr 664.24Cr 1.26TCr 84TCr 1.28TCr 8.55TCr 3.32TCr 41TCr 3.33TCr 3.26TCr 1,43000Cr
Net Debt 4.17TCr 22TCr 3.65TCr 3.35TCr 3.12TCr 5.92TCr 3,97000Cr 6.01TCr 40TCr 16TCr 1,95000Cr 16TCr 15TCr 6,72900Cr 3.61TCr 19TCr 3.15TCr 2.89TCr 2.7TCr 5.12TCr 3,43300Cr 5.2TCr 35TCr 14TCr 1,68600Cr 14TCr 13TCr 5,81700Cr
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
02/26/02 R$69.10 +4.19% 1,015
29/26/29 R$66.32 +0.15% 1,728
26/26/26 R$66.22 +0.53% 522
25/26/25 R$65.87 +0.81% 1,531
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
374.15USD
Average target price
354.76USD
Spread / Average Target
-5.18%

Quarterly revenue - Rate of surprise